Novo Nordisk A S

NVO chart

Novo Nordisk A S news

• Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care

  Yahoo Finance · Nov 11, 4:30 AM EST

• Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

  247wallst.com · Nov 10, 1:52 PM EST

• European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

  Yahoo Finance · Nov 10, 11:15 AM EST

• Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?

  fool.com · Nov 10, 11:04 AM EST

• Hims & Hers Sinks 9% on EBITDA Guidance Cut as CEO Says He’d Take Subscriber Losses “Every Time”

  tikr.com · Nov 10, 9:57 AM EST

• Hims & Hers Stock Plunges Despite 49% Revenue Surge

  Yahoo Finance · Nov 10, 9:53 AM EST

• Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know

  Yahoo Finance · Nov 10, 8:00 AM EST

• The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed.

  ibtimes.com · Nov 10, 7:41 AM EST

• What Does Novo Nordisk (CPSE:NOVO B) FDA Vision Warning Mean For Investors?

  Yahoo Finance · Nov 10, 6:13 AM EST

• Novo Nordisk (NVO) Stock Price Prediction: Rally tests resistance after Novo raises outlook and Binance flows lean long

  Blockchain News · Nov 9, 6:33 PM EST

• Eli Lilly’s Weight-Loss Pill Shows Sleep Apnea Benefits. Can It Gain on Novo?

  Yahoo Finance · Nov 9, 2:27 PM EST

• Sector Update: Healthcare Stocks Rise Monday Afternoon

  Yahoo Finance · Nov 9, 1:36 PM EST

Novo Nordisk A S key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-11-09
• 6-KFORM 6-K2026-11-05
• 6-K6-K2026-11-04
• 6-KFORM 6-K2026-11-03
• 6-KFORM 6-K2026-10-26
• 6-KFORM 6-K2026-10-19
• 6-KFORM 6-K2026-10-13
• 6-KFORM 6-K2026-10-06
• 6-KFORM 6-K2026-10-05
• 6-KFORM 6-K2026-09-28
• 6-KFORM 6-K2026-09-21
• 6-KFORM 6-K2026-09-17

About Novo Nordisk A S

Ticker

NVO (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Bagsvaerd Denmark, Denmark

Fiscal year end

December 31

SEC CIK

353278

Frequently asked questions